Coinbase Raises $100 Mln Coinbase has raised $100 million in funding, giving the cryptocurrency

VC Watch: Digital Currency Exchange Coinbase Raises $100 Mln

VC Watch: Digital Currency Exchange Coinbase Raises $100 Mln

 Coinbase Raises $100 Mln Coinbase has raised $100 million in funding, giving the cryptocurrency

 Coinbase Raises $100 Mln Coinbase has raised $100 million in funding, giving the cryptocurrency exchange a post-money valuation of $1.6 billion. The latest funding round makes the company a unicorn, a start-up having a valuation of $1 billion or more.

The Series D funding round was led by IVP, with participation from Spark Capital, Greylock Partners, Battery Ventures, Section 32 and Draper Associates. Coinbase has previously raised a total of $106 million.

According to Coinbase, it has now exchanged over $25 billion of digital currency for its customers. The company, founded in 2012, plans to use the new funding to expand even further.

Coinbase said it will increase the size of its engineering and customer support teams as well as open a GDAX office in New York City. It will also invest in Toshi, a browser for the Ethereum network, to help accelerate digital currency’s shift from speculative investment to global payment network.



Coinbase Raises $100 Mln

“Digital currencies are having their ‘Netscape’ moment. The pace of innovation has been accelerating and we are now seeing exciting projects and companies being built on top of digital currencies. We’re beginning to transition into phase three of our secret master plan,” Brian Armstrong, Co-founder and CEO of Coinbase said.

Currently, Coinbase is a digital currency company with support for Bitcoin, Ethereum and Litecoin in 32 countries.

Earlier in August, Coinbase rejected the new Bitcoin Cash after digital currency Bitcoin’s much-anticipated split into two and said its systems cannot support it. According to Coinbase, it would be time-consuming and expensive to create secure infrastructure to trade bitcoin cash.

However, Coinbase later said it plans to have support for bitcoin cash by January 1, 2018.

|Chart | Calendar   | TRADE NOW | FORCAST | cryptocurrency 

Market Quotes by TradingView




Like up on FACEBOOK


logo

( ethereum logoETH )  (bitcoin logo BTC )  ( ripple logo XRP )  (  litecoin logoLTC )  (DASH LOGO  DASH )  ( NEM LOGO NEM ) ( ethereum-classic LOGO ETC )



BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Investors Buzz Equity Stocks watch next week

Investors Buzz Equity Stocks to watch next week

Stocks watch next week Key events are scheduled for the companies listed below next week.

Stocks watch next week Key events are scheduled for the companies listed below next week.

Notable earnings reports: Retailers dominate the list this week, led by Target (NYSE:(TGT) on August 16 and Wal-Mart (NYSE:(WMT) on August 17. Also reporting are Coach (NYSE:(COH), Dick’s Sporting Goods (NYSE:(DKS) on August 14; Urban Outfitters (NASDAQ:(URBN), Home Depot (NYSE:(HD) on August 15; Cisco (NASDAQ:((CSCO), L Brands (NYSE:LB) on August 16; Alibaba (NYSE:(BABA), Gap (NYSE:(GPS) on August 17; Foot Locker (NYSE:(FL), Deere (NYSE:(DE) on August 18.

Expected IPO filings: Capitol Investment Corp. (Pending:CIC.U).

Go-shop expiration: Rocket Fuel (NASDAQ:(FUEL) for the Vector deal.

IPO quiet period expirations: Calyxt (Pending:(CLXT) on August 14, Kala Pharmaceuticals (Pending:(KALA) on August 14; PetIQ (Pending:PETQ) on August 15.

Secondary offering lockup expirations: Bluebird Bio (NASDAQ:(BLUE), Carrizo Oil & Gas (NASDAQ:(CRZO), Ziopharm Oncology (NASDAQ:(ZIOP), Loco Oncology (NASDAQ:(LOXO) on August 14; Five Oaks Investment (NYSE:(OAKS), Alcentra Capital (NASDAQ:(ABDC) on August 15; Advance Disposal Services (NYSE:(ADSW) on August 16; Halozyme Therapeutics (NASDAQ:(HALO), Indentiv (NASDAQ:(INVE), Harte Hanks (NYSE:(HHS) on August 17



Stocks watch next week

 

Notable annual meeting: Pangaea Logistics (NASDAQ:(PANL) on August 14, Canadian Goose (NYSE:(GOOS) on August 15, J.M. Smucker (NYSE:(SJM) on August 16.

Special shareholder meetings: Care Capital Properties (NYSE:(CCP), FelCor Lodging (NYSE:(FCH), RLJ Lodging (NYSE:(RLJ) on August 15; Rent-A-Center (NASDAQ:(RCII) on August 17, Albany Molecular Research (NASDAQ:(AMRI) on August 18.

Sales and revenue update: Charles Schwab (NYSE:(SCHW) on August 14.

Credit card charge-off reports: American Express (NYSE:(AXP), Bank of America (NYSE:BAC), Citigroup (NYSE:C), Capital One (NYSE:(CO), Discover Financial (NYSE:DFS), JPMorgan (NYSE:JPM) and Synchrony Financial (NYSE:(SYF).

Analyst/Investor day: Humana (NYSE:(HUM) on August 14; Equifax (NYSE:(EFX) on August 15; Progressive (NYSEARCA:(PGF), Unisys (NYSE:(UIS), IDEXX (NASDAQ:(IDXX) on August 16; Rogers Corporation on August 17.

Media watch: A week after the Disney (NYSE:(DIS)-Netflix bombshell, media heavyweights gather on August 15 at the Nomura Instinet Media & Telecom conference in NYC. Presenters include Akamai (NASDAQ:AKAM), AMC Networks (NYSE:AMC), AT&T (NYSE:T), CBS (NYSE:(CBS), Juniper Networks (NYSE:(JNPR), Lions Gate (LGF.A, LGF.B), Sprint (NYSE:S), Twenty-First Century Fox (NASDAQ:FOXA) and Verizon (NYSE:(VZ). Also of interest is a talk by NBA execs with sports a large streaming wildcard.

FDA watch: Seattle Genetics (NASDAQ:(SGEN) is expected to find out by August 20 if Adcetis has been accepted for review.

Hedge fund watch: Pershing Square will hold a webcast with investors on August 17.

Barron’s mentions: The cover story warns on a 50% drop for Netflix (NASDAQ:(NFLX), while 50% upside is seen for Volkswagen (OTCPK:(VLKAY) with breakup opportunities in the air. Microsoft (NASDAQ:(MSFT) and General Dynamics (NYSE:(GD) land very favorable write-ups. On the flip side, the huge drops from IPO duds Snap (NYSE:(SNAP) and Blue Apron (NYSE:(APRN) catch some attention.

Sources: EDGAR, Bloomberg, Nasdaq.com.

Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



DAY AHEAD  Here’s a preview of the top 3 things that could rock markets tomorrow

DAY AHEAD: TOP 3 THINGS TO WATCH

DAY AHEAD: TOP 3 THINGS TO WATCH

DAY AHEAD  Here’s a preview of the top 3 things that could rock markets tomorrow

DAY AHEAD  Here’s a preview of the top 3 things that could rock markets tomorrow

U.S. crude oil stockpiles to show sixth-straight weekly decline?

A fresh batch of inventory data from the Energy Information Administration (EIA) on Wednesday is expected to show that U.S. crude stockpiles fell for a sixth-straight week.

Analysts forecast crude inventories fell by about 2.7m barrels in the week ended Aug 4.

Crude futures have started the week on the back foot, struggling to settle above $50 amid an uptick in production from major oil producers.

Crude oil prices settled $0.22 lower at $49.17 on Tuesday as market participants await the outcome of a two-day compliance meeting of Opec and non-Opec members.

It’s rate decision day… In New Zealand



DAY AHEAD

The Reserve Bank of New Zealand (RBNZ) is slated to reveal its decision interest rates on Wednesday, widely expected to remained unchanged at 1.75%.

Investors, however, will parse the policy statement on Wednesday to establish whether the central bank continues to believe that rates should be kept “lower for longer” amid declining inflation and labour market data and a cooling housing market.

Ahead of the RBNZ decision on interest rates, NZD/USD fell 0.49% to $0.7325.

Walt Disney to drag markets down

Walt Disney Company (NYSE:DIS) could be stock to watch on Wednesday, following the release of mixed third quarter results, as earnings topped estimates but revenue fell short.

Walt Disney earned $1.58 per share in the third quarter, above the consensus analyst forecast for $1.58. Revenue was $14.24 billion, $180 million short of what analysts had forecast.

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)



Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment,

Two Medical Marijuana Penny Stocks to Watch Out for in the Wake of Complete Weed Legalization in 2017

Weed Legalization in the U.S.

Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment,

Marijuana Penny Stocks With so much excitement building around the potential breakout of a legal recreational pot business open for investment, the very profitable medical marijuana business usually gets overlooked. For those investing in marijuana stocks, that’s a big mistake. The top medical marijuana penny stocks have the potential to provide even more lucrative returns.

It’s important to remember that the path to weed legalization in the U.S. is on two different tracks for medicinal and recreational marijuana. While recreational marijuana is gaining steam across the U.S., with Nevada being the latest state to enshrine the legal usage of marijuana into law, it’s still a far ways behind on medicinal marijuana.



 Marijuana Penny Stocks

While the majority of Americans do believe that marijuana should be legalized, both federally and statewide, the process is slow-going in terms of mass legalization. Sure, the most populous state in the country, California, has legal weed, as well as several other states and D.C., but that’s still nowhere near full acceptance. Not to mention that the drug is still illegal federally, meaning that technically, national agents could come in and close down every single recreational marijuana dispensary in the country.

You see, under the Obama administration, while not directly endorsing marijuana use, the former president and his team tacitly condoned states moving towards more legalization as federal agents stayed out of the states’ way once legislation was passed.

With that blow coming towards the Sessions crusade against marijuana and Booker pushing legislation, it was a great past week for the marijuana industry.

So with that good new coming in spades, let’s take a look at the marijuana stock list that shows two medical marijuana stocks I think are two of the top medical marijuana penny stocks.

Top Medical Marijuana Penny Stocks

weed3

Chart courtesy of StockCharts.com

Aphria Inc (TSE:APH)

Aphria has a lot going for it. It’s based out of Canada, which is set to legalize all forms of marijuana use by summer 2018. It has a novel way of growing its product—through greenhouses—that will lend it a competitive advantage. And it already supplies a good portion of medical marijuana to the market.

Canopy Growth Crop (TSE:WEED)

As the biggest player in the marijuana market, with a market cap of nearly $1.5 billion, it’s easy to see why such a huge and respected player in the market would be a solid penny stock.

In fact, it’s quite surprising that WEED stock is among the top medical marijuana penny stocks considering its size, but with the value of its shares well below $10.00, WEED stock is still in the penny stock phase of growth.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

 


 



Buz Investors Best Biotech Stock 2017 The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors.

4 Biotech Stocks to Watch This Quarter

36px) Fz(25px)--sm Fz(32px) Mb(17px)--sm Mb(20px) Mb(30px)--lg Ff($ff-primary) Lts($lspacing-md) Fw($fweight) Fsm($fsmoothing) Fsmw($fsmoothing) Fsmm($fsmoothing) Wow(bw)" data-reactid="3">4 Biotech Stocks to Watch This Quarter

Buz Investors Best Biotech Stock 2017 The biotech industry is one of the more lucrative–if volatile–sectors around for heady investors.

Biotech Stocks The biotech sector could easily continue to grow. Why? The long-term trends that have made the sector an outperformer in the market over the past five years remain in place. Biotechnology stocks continue to maintain a strong pace amid phase trials, new leadership and big investments from insiders.

Before the 2016 U.S. presidential election, the biotech industry itself was in a downward trend with many expecting Hillary Clinton to become president and put pressure on big pharma. Once President Trump took office, biotechnology stocks took on a much brighter spotlight. This has been clearly evidenced by the dramatic shift in the Nasdaq Biotechnology Index (NBI). The index itself has increased by as much as 33% after hitting new highs earlier in July.

In line with this, the Nasdaq Biotech Index (in blue, above) continues to outpace both the S&P500 (in green) and the Nasdaq (in red). The regulatory environment in the U.S. leans in favor of biotechnology, with the Food and Drug Administration offering fast-track approval for some breakthrough drugs, especially those targeting rare diseases.



Biotech Stocks

Oxis International Inc. (OXIS), for example, develops and commercializes innovative immunotherapeutics and has a robust portfolio. Oxis has a portfolio of next-generation cancer initiatives and its lead drug candidate, OXS-1550. In fact, the first patient has begun treatment in a FDA-approved Phase 2 clinical trial of its cancer therapy.

Dr. Daniel Vallera, director of the section on Molecular Cancer Therapeutics at the University of Minnesota Cancer Center, helped develop OXS-1550. He commented on the drug.

“The initiation of Phase 2 patient treatment is a key opportunity to demonstrate the effectiveness of this promising cancer therapy,” Vallera said. “This brings us one step closer to an important alternative to invasive chemotherapies and costly cell therapies, Kite Pharma, Inc. (KITE), Juno Therapeutics (JUNO), for cancer patients.”

Oxis recently announced it has signed a binding letter of intent agreement to acquire Georgetown Translational Pharmaceuticals Inc. Formal completion of this agreement will allow Oxis to acquire Georgetown Translational’s leading candidate, Pain Brake. This therapy is a pain relief drug expected to be submitted to the FDA as a new drug application in 15 to 18 months.

Dr. Kathleen Clarence-Smith, co-founder of Chase Pharmaceuticals Corp. (acquired by Allergan PLC (AGN)), will become the new CEO of Oxis and the company has also proposed a name change to GT Biopharma Inc. as part of the transaction.

Similar to Oxis, Moleculin Biotech Inc. (MBRX) also recently announced adding members to the company. In late July, Moleculin appointed John M. Climaco as an independent member of the board of directors.

“We are pleased to have John join our Board as he brings a wealth of international business successes managing complex operations in addition to his well-established capabilities in capital markets, product commercialization and business development,” Moleculin CEO Walter Klemp said.

Recently, the company has been focused on providing support to help jumpstart the launch of a physician-sponsored investigational new drug (IND) application to study the company’s WP1066. This drug is designed for the treatment of adult brain tumors (glioblastoma).

“By providing additional guidance and data, we think we can help accelerate the ability of the physician investigator to respond to FDA’s requests in a way that will allow the study to begin, which we believe could position WP1066 for a brain tumor trial this year,” Klemp said in a press release.

Moleculin share prices have jumped since late June to as high as $3.75. On July 31, the stock closed at $2.99, which was up over 100% since July 10.

Another biotech stock in focus is BioLineRX Ltd. (BLRX). The company is in its clinical stages and focusing on oncology and immunology. It is currently working on a combination trial of BL-8040 (the company’s lead oncology platform) and atezolizumab in order to develop a cancer immunotherapy combination. Genentech, a member of the Roche Group, has begun a Phase 1b/2 study for BL-8040 in order to evaluate the combination in metastatic pancreatic ductal adenocarcinoma.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



ECONOMIC CALENDAR Global financial markets will focus on a big batch of U.S. economic data in the week ahead, with Friday’s inflation repor

THE WEEK AHEAD: 5 THINGS TO WATCH ON THE ECONOMIC CALENDAR

THE WEEK AHEAD: 5 THINGS TO WATCH ON THE ECONOMIC CALENDAR

ECONOMIC CALENDAR Global financial markets will focus on a big batch of U.S. economic data in the week ahead, with Friday’s inflation repor

ECONOMIC CALENDAR Global financial markets will focus on a big batch of U.S. economic data in the week ahead, with Friday’s inflation report in the spotlight, for further clues on the timing of the next Federal Reserve rate hike.

Investors will also keep an eye out on a number of Fed speakers for any new insight on when and how the central bank plans to pare back its massive balance sheet.

Elsewhere, China is to release monthly trade and inflation data amid recent signs that momentum in the world’s second largest economy remains strong.

In the U.K., traders will be awaiting a report on manufacturing production for further indications on the continued effect that the Brexit decision is having on the economy.

 



 

ECONOMIC CALENDAR

Meanwhile, market players await monthly reports from the Organization of Petroleum Exporting Counties and the International Energy Agency to assess global oil supply and demand levels.

Ahead of the coming week, Investing.com has compiled a list of the five biggest events on the economic calendar that are most likely to affect the markets.

1. U.S. inflation data

The Commerce Department will publish inflation figures for July at 8:30AM ET (1230GMT) Friday. Market analysts expect consumer prices to ease up 0.2%, while core inflation is forecast to rise 0.2%.

On a yearly base, core CPI is projected to climb 1.7%. Core prices are viewed by the Federal Reserve as a better gauge of longer-term inflationary pressure because they exclude the volatile food and energy categories. The central bank usually tries to aim for 2% core inflation or less.

Rising inflation would be a catalyst to push the Fed toward raising interest rates in the months ahead.

Besides the inflation data, this week’s calendar also features reports on JOLTS job openings, nonfarm productivity and unit labor costs, producer prices as well as weekly jobless claims.

In the stock market, struggling retailers, such as Macy’s (NYSE:M), Nordstrom (NYSE:JWN), Kohl’s (NYSE:KSS) and JC Penney (NYSE:JCP), will release results in the week ahead, as earnings season begins to wind down. Media companies, like Disney (NYSE:DIS) and News Corp (NASDAQ:NWSA), as well as some recent IPOs, including Snap (NYSE:SNAP) and Blue Apron (NYSE:APRN), will also garner some attention.

Focus will also be on headlines coming out of Washington, even as Congress slows down for August recess. The investigation into U.S. President Donald Trump campaign’s ties to Russia will remain on the agenda.

2. Fed speakers

A handful of Fed policymakers are due to make public appearances this week that may offer fresh clues on future monetary policy moves.

Monday sees St. Louis Fed President James Bullard and Minneapolis Fed President Neel Kashkari make public appearances.

On Thursday, New York Fed President William Dudley will speak about wage inequality in his region. His comments will be scrutinized to gauge whether the Fed’s view on low inflation appears to be transitory or a longer term problem.

Finally, Friday sees Dallas Fed President Rob Kaplan and Minneapolis Fed chief Kashkari deliver comments.

Markets remain skeptical the Fed will raise rates in December, according to Investing.com’s Fed Rate Monitor Tool, due to worries over the subdued inflation outlook, but it is widely expected to start the process of reducing its balance sheet by September.

3. China trade figures

China is to release July trade figures at around 0300GMT on Tuesday. The report is expected to show that the country’s trade surplus widened to $46.08 billion last month from a surplus of $42.77 billion in June.

Exports are forecast to have climbed 10.9% in July from a year earlier, following a jump of 11.3% a month ago, while imports are expected to rise 16.6%, after increasing 17.2% in June.

Additionally, on Wednesday, the Asian nation will publish data on July consumer and producer price inflation. The reports are expected to show that consumer prices rose 1.5% last month, while producer prices are forecast to increase by 5.5%.

China’s economy grew a faster-than-expected 6.9% in the second quarter, matching the first quarter’s pace, supported by solid exports, industrial production and consumption.

4. U.K. manufacturing production

The Office for National Statistics is to produce data on U.K. manufacturing production for June at 0830GMT (4:30AM ET) on Thursday, amid expectations for a flat reading, following a decline of 0.2% in the preceding month. Industrial output is forecast to inch up 0.1%, after falling 0.1% in May.

The Bank of England cut its forecasts for growth and wages last week, and appeared in no rush to raise interest rates, as it warned that Brexit was weighing on the economy.

5. OPEC/IEA monthly reports

The Organization of Petroleum Exporting Counties will publish its monthly assessment of oil markets at around 7:00AM ET (1100GMT) on Thursday. It includes figures on the state of global crude stockpiles for July.

On Friday, the International Energy Agency will release its own monthly report on global oil supply and demand.

The data will give traders a better picture of whether a global rebalancing is taking place in the oil market.

Oil traders will also be focused on a meeting of oil ministers from some OPEC and non-OPEC countries set for Monday and Tuesday in Abu Dhabi to discuss compliance to agreed upon global production limits that run through March 2018.

So far, the output deal has had little impact on global inventory levels due to rising supply from producers not participating in the accord, such as Libya and Nigeria, as well as a relentless increase in U.S. shale output.

Like up on FACEBOOK


Hashing24 : Cloud Mining

logo



major currencies: (EUR-USD) (USD-JPY) (USD-GBP) (USD-CHF), (USD-CAD), (AUD-USD) (USDCNY)



BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

Forex Investors Buzz Stocks to watch next week August 7-11

Forex Investors Buzz Stocks to watch next week August 7-11

BUZ INVESTORS Market Open U.S. missile attack on Syria puts markets on edge. The order of the missile attack on Syria

STOCK TRADERS 

Key events are scheduled for the companies listed below next week.

Notable earnings reports: Marriott International (NYSE:)MAR), CBS (NYSE:(CBS) and Tyson Foods (NYSE:(TSN) on August 7; Disney (NYSE:DIS), Priceline (NASDAQ:(PCLN), Wayfair (NYSE:W), Michael Kors (NYSE:KORS) on Augusy 8; Ctrip.com (NASDAQ:(CTRP), Mobileye (NYSE:(MBLY) and Mylan (NASDAQ:(MYL) on August 9; Nvidia (NASDAQ:(NVDA), Alibaba (NYSE:(BABA), Macy’s (NYSE:(M) and News Corp (NASDAQ:(NWSA) on August 10; J.C. Penney (NYSE:(JCP) on August 11.

Expected IPO pricings: Zealand Pharma (Pending:ZLND) on August 8, Contura Energy (Pending:CTRA) on August 9, Ranger Energy Services (Pending:RNGR) on August 10.

IPO quiet period expirations: Avenue Therapeutics (NASDAQ:(ATXI), Esquire Financial (Pending:(ESQ), Mersana Therapeutics (NASDAQ:(MRSN); Aileron Therapeutics (NASDAQ:(ALRN), Blue Apron (NYSE:(APRN), Dova Pharmaceuticals (NASDAQ:DOVA) on August 8; Byline Bancorp (NYSE:BY), Tintri (NASDAQ:TNTR) on August 9.



Stocks to watch

Secondary offering lockup expirations: Aeglea BioTherapeutics (NASDAQ:(AGLE), Exact Sciences (NASDAQ:(EXAS), Evolent Health (NYSE:(EVH), Ctyokinetics (NASDAQ:(CYTK) on August 7; Monroe Capital (NASDAQ:(MRCC), Accelerate Diagnostics (NASDAQ:(AXDX) on August 8; Becton Dickinson (NYSE:BDX) on August 9, Foundation Building Materials (NYSE:FBM) on August 9; Kinsdale Capital (Pending:(KNSL), TPI Composite (NASDAQ:(TPIC) on August 10.

Notable annual meeting: Pandora (NYSE:P) on August 7, Ralph Lauren (NYSE:(RL) on August 10, Merrimack Pharmaceuticals (NASDAQ:(MACK) on August 11.

Special shareholder meetings: Farmers National Banc (OTCPK:(FMBN) on August 8, Central Valley Community Bancorp (NASDAQ:(CVCY), Folsom Lake Bank (OTCPK:(FOLB) on August 10.

Analyst/Investor day: BorgWarner (NYSE(BWA) on August 7, Equifax (NYSE:(EFX) on August 9.

Business update call: Barnes & Noble Education (NYSE:(BNED) on August 7

FCC watch:: The deadline for the agency to deny Sinclair Broadcast’s (NASDAQ:(SBGI) purchase of Tribune Media (NYSE:(TRCO) is August 8.

FDA watch: Gilead (NASDAQ:(GILD) expects to find out if its single tablet daily regimen for HIV is accepted for review. TherapeuticsMD (NYSEMKT:(TXMD) to receive Advice Letter on TX-004HR. A drug approval call is scheduled for Jazz Pharmaceuticals on August 7.

Sales and revenue update: TD Ameritrade (NASDAQ:(AMTD) on August 7, WestJet Airlines (OTC:(WJAFF) on August 10.

JPMorgan Auto Conference: Presenters for the event from August 8-9 include Adient (NASDAQ:(ADNT), Dana (NYSE:(DAN), Visteon (NYSE:(VC), Cooper Tire & Rubber (NYSE:(CTB), Delphi Automotive (NYSE:(DLPH), General Motors (NYSE:GM), LKQ Corporation (NASDAQ:(LKQ), Stoneridge (NYSE:(SRI) and Avis Budget (NASDAQ:(CAR).

Barron’s mentions: Watch for Amazon (NASDAQ:AMZN), Facebook (NASDAQ:(FB) and Google (GOOG, (GOOGL) to make a major push into sports TV beyond occasional streaming to challenge ABC/ESPN, Fox (NASDAQ:(FOXA), CBS, and NBC (NASDAQ:(CMCSA)

CMCSA
$39.60
 -0.41 -1.02%
Comcast Corporation Class A
Provides entertainment, information and communications products and services
52 Week Range
30.02 – 42.18
Market Cap.
187.78B

). Big gains are seen for Delta Air Lines (NYSE:(DAL), Finisar (NASDAQ:(FNSR) and Voya Financial (NYSE:(VOYA). There’s some caution expressed on Tesla (NASDAQ:(TSLA). Despite the rave reviews on the Model 3, the stock is seen as “priced to perfection” into the production ramp.

Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



INVESTORS DAY AHEAD Here’s a preview of the top 3 things that could rock markets tomorrow

THE INVESTORS DAY AHEAD: TOP 3 THINGS TO WATCH

THE INVESTORS DAY AHEAD: TOP 3 THINGS TO WATCH

INVESTORS DAY AHEAD Here’s a preview of the top 3 things that could rock markets tomorrow

INVESTORS DAY AHEAD Here’s a preview of the top 3 things that could rock markets tomorrow

Its ‘Jobs Friday’

Non-farm payrolls, arguably one of the most important economic events of the month, will help investors assess the strength of the U.S. economy, and provide the dollar, U.S. 10-Year, and gold with fresh direction, as labor market conditions are one the measures the Federal Reserve considers in its monetary policy decisions.

Analysts forecast that the U.S. economy created about 183,000 jobs in June while the unemployment rate is expected to tick lower to 4.3%.

Heading into Friday’s non-farm payrolls report, investor sentiment remained bearish, after private sector payrolls, widely viewed as a precursor to non-farm payrolls, showed a slowdown in private sector job creation, suggesting a cooling labor market.



 INVESTORS DAY AHEAD

Baker Hughes rig count

The weekly instalment of drilling activity from Baker Hughes on Friday, will provide investors with fresh insight into U.S. oil production and demand, after the number of active drilling rigs has slowed in recent weeks.

The weekly rig count is an important barometer for the drilling industry and serves as a proxy for oil production and oil services demand.

At Thursday’s settlement price, crude futures remained on track to snap a three-week winning streak amid concerns over a tick lower in Opec compliance with the deal to curb production.

GoPro to soar on US market open?

GoPro Inc (NASDAQ:GPRO) reported quarterly results that beat analysts\’ expectations on Thursday, posting a narrower loss per share and larger revenue than expected for the quarter.

GoPro posted an earnings loss of 9 cents per share on $296.5 million in revenue, confounding Wall Street estimates of an earnings loss of 25 cents per share on $269.6 million in revenue.

Shares of GoPro initially soared 17% after the report was released, but gave up some of its gains to trade at $9.01, up 9.08%, in after hours trading.

The stock has fallen more than 4% so far this year.Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )



 DAY AHEAD Here’s a preview of the top 3 things that could rock markets tomorrow

THE DAY AHEAD: TOP 3 THINGS TO WATCH

THE DAY AHEAD: TOP 3 THINGS TO WATCH

FOREX INVESTORS BUZZ 

TOP 3 THINGS  Here’s a preview of the top 3 things that could rock markets tomorrow

TOP 3 THINGS  Here’s a preview of the top 3 things that could rock markets tomorrow

BoE rate decision

GBP/USD could be the ‘one to watch’, as the Bank of England reveals its decision on interest rates, widely expected to remained unchanged at 0.25%.

The rate decision comes amid growing expectations the Bank of England will announce its attention to begin tapering its ultra-accommodative monetary policy sometime later this year, following hawkish remarks in early July from BoE Governor Mark Carney.

Carney raised the prospect of the removal of some UK monetary stimulus, saying “some removal of monetary stimulus is likely to become necessary if the trade-off facing the [Monetary Policy Committee] continues to lessen and the policy decision accordingly becomes more conventional”.



TOP 3 THINGS

 

Tesla to power the Dow to another record high?

Shares of Tesla Inc (NASDAQ:TSLA) were rallying in the after hours session after the company released its second quarter results, which came in better than analysts were expecting.

A solid quarter of deliveries of its high-end Model S sedans and sports utility vehicle Model X, spurred better-than-expected performance on both the top and bottom line.

Tesla lost $1.33 per share in the quarter, better than the $1.80 analyst forecast compiled by Yahoo Finance. Revenue was $2.8 billion, up 120.5% year-over-year, and above the $2.55 billion analysts were expecting.

The rally in the Dow could be extended on Thursday, should shares of Tesla continue to add to gains from after hours trading.

Tesla shares rose more than 5% in the after hours to $344.59

US macro data on tap

Market participants look ahead to the release of a duo of economic reports on Thursday, which may offer further guidance on the strength of U.S. economy.

Non-manufacturing economic data for July is expected show steady growth in the services sector.

Economists expect a reading of 57 for the month, down a slightly from 57.4 in the previous month.

On the jobs data front, economists forecast a 2,000 decline to 242,000 in the number of individuals who filed for unemployment insurance for the week ended July 30.

Ahead of nonfarm payrolls due Friday, the dollar has slumped to new lows for the year against its rivals amid a drop in investor expectations the Federal Reserve will keep to its plan to raise rates at least once more this year.

Like up on FACEBOOK




Market quotes are powered by
TradingView.com



Tech Stocks ( GOOG)   (MSFT ) ( AAPL ) (BBRY ) ( gopro )  ( WDC )